Congress Rakes In Millions From Drugmakers
In the first six months of this year, pharmaceutical firms and their trade groups donated almost $4 million to the campaigns of a variety of senators and House members.
Drugs
721 - 740 of 1,297 Results
-
-
Legislation To End Surprise Medical Bills Has High Public Support 鈥 In Both Parties
Almost 80% of Americans support efforts in Congress to protect patients from bills that come from doctors or hospitals that were outside their insurance network.
-
States Pass Record Number Of Laws To Reel In Drug Prices
So far this year, 33 states have enacted more than 50 measures to address drug prices, affordability and access. Congress is eyeing the efforts to see what works.
-
Listen: India Gives Opioid Makers A Huge And Growing New Market
KHN's Sarah Varney discussed opioid painkillers in India with NPR's Rachel Martin on "Morning Edition" Thursday.
-
Americans More Likely Than Swedes To Fill Prescriptions For Opioids After Surgery
New research published in JAMA Network Open quantified for the first time international differences in doctors鈥 prescribing habits and patients鈥 use of these highly addictive painkillers.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Shopping At The Apotheke: Compare German Pharmacies With Your Corner Drugstore
Germany鈥檚 pharmacies provide insights into the country鈥檚 low drug prices and strict regulations. But they鈥檙e still businesses.
-
In India鈥檚 Slums, 鈥楶ainkillers Are Part Of The Daily Routine鈥
As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patients鈥 pain, the nation鈥檚 sprawling, cash-fed health care system is ripe for misuse.
By Sarah Varney -
Beset By Lawsuits And Criticism In U.S., Opioid Makers Eye New Market In India
What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home.
By Sarah Varney -
Pharma Cash Rolls Into Congress To Defend An Embattled Industry
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.
-
Judge Cites Opioid ‘Menace,’ Awards Oklahoma $572M In Landmark Case
The state judge ruled that drugmaker Johnson & Johnson contributed to the opioid epidemic that has claimed the lives of 6,000 Oklahomans.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Readers And Tweeters Take Dialysis Providers To Task: Nowhere But In The USA
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
KHN鈥檚 鈥榃hat The Health?鈥: All About Medicare
Before 鈥淢edicare for All,鈥 there was just Medicare, the federal program that provides insurance to 60 million Americans. This week, KHN鈥檚 Julie Rovner talks to Tricia Neuman of the Kaiser Family Foundation about how Medicare works and whom it serves. Then, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Kimberly Leonard of the Washington Examiner join Rovner to talk about some current Medicare issues being debated in Washington, D.C.
-
Shopping Abroad For Cheaper Medication? Here鈥檚 What You Need To Know
Americans routinely skirt federal law by crossing into Canada and Mexico or tapping online pharmacies abroad to purchase prescription medications at a fraction of the price they would pay at home. Is it safe? Not necessarily. Here鈥檚 some advice.
-
MDMA, Or Ecstasy, Shows Promise As A PTSD Treatment
MDMA, the psychoactive ingredient in the club drug known as molly or ecstasy, is being tested in combination with therapy as a treatment for severe trauma.
-
Among Hurdles For Those With Opioid Addictions: Getting The Drug To Treat It
It can be difficult to get a prescription for buprenorphine, one of the gold standards for treating opioid use disorder. And not all pharmacies stock the drug.
-
KHN鈥檚 鈥榃hat The Health?鈥: We Answer Your Questions
You asked about drug prices, the 鈥淐adillac tax鈥 on generous insurance plans and why Americans don鈥檛 know that most other countries also have combination public-private insurance systems. This week, Anna Edney of Bloomberg News, Alice Miranda Ollstein of Politico and Caitlin Owens of Axios join KHN鈥檚 Julie Rovner to answer those questions.
-
Doctors Can Change Opioid Prescribing Habits, But Progress Comes In Small Doses
Research out Wednesday indicates that guidelines are making strides in cutting back the number of pain pills doctors offer after specific types of surgeries.
By Julie Appleby and Elizabeth Lucas -
KHN鈥檚 鈥榃hat The Health?鈥: Gun Violence And The Politics Of Public Health
The recent tragic mass shootings have refocused efforts to treat gun violence as a public health issue rather than strictly a law enforcement problem. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Agnes Carey of Kaiser Health News join KHN鈥檚 Julie Rovner to discuss this, plus the health implications of the budget deal passed by Congress and signed by President Donald Trump, as well as reaction from Canada to a proposal to allow broader imports of its prescription drugs. Plus, for 鈥渆xtra credit,鈥 the panelists recommend their favorite health stories of the week.